EIKONIZO
Updated 626 days ago
245 Main Street, 2nd Floor Cambridge, MA 02142
Eikonizo is developing brain-penetrant, small molecule, selective histone deacetylase 6 (HDAC6) inhibitors as disease-modifying therapeutics for neurodegenerative diseases, focusing first on amyotrophic lateral sclerosis (ALS).